Rolf Jorde1, Ellisiv Bøgeberg Mathiesen2, Sigbjørn Rogne3, Tom Wilsgaard4, Marie Kjærgaard5, Guri Grimnes6, Henrik Schirmer7. 1. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Division of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway; The School of Population Health, University of Auckland, Auckland, New Zealand. Electronic address: rolf.jorde@unn.no. 2. Brain and Circulation Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Norway; Department of Neurology and Neurophysiology, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: ellisiv.mathiesen@ism.uit.no. 3. Division of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: sigrogne@online.no. 4. Department of Community Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway. Electronic address: tom.wilsgaard@ism.uit.no. 5. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Division of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: marie.kjaergaard@unn.no. 6. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Division of Internal Medicine, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: guri.grimnes@unn.no. 7. Department of Clinical Medicine, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Division of Cardiothoracic and Respiratory Medicine, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: h.schirmer@ucl.ac.uk.
Abstract
BACKGROUND AND PURPOSE: There are indications that vitamin D may be important for more than skeletal health, including cognitive function. METHODS: The study was performed in Tromsø, Northern Norway (The Tromsø Study). In a cross-sectional study serum 25-hydroxyvitamin D (25(OH)D) was measured and cognitive function (word recall, digit-symbol coding, finger tapping, Mini Mental State Examination) tested in 4624 subjects; in a prospective study serum 25(OH)D was measured in samples from 1994 and compared to cognitive function tested in 3436 subjects in 2001 and 2044 subjects in 2007; and in a Mendelian randomization study single nucleotide polymorphisms (SNPs) related to vitamin D were evaluated versus cognitive function in 5980 subjects. RESULTS: In the cross-sectional study all tests were positively associated with serum 25(OH)D levels with ~5% better performance in subjects in the highest versus lowest serum 25(OH)D quartile. This relation was only seen in subjects older than 65 years. After full adjustment for season, age, gender, body mass index, blood pressure, physical activity and education, the relation was only significant for finger tapping. In the prospective study, serum 25(OH)D from 1994 similarly predicted cognitive function 7-13 years later. In the Mendelian randomization study, only one SNP in the VDR gene (Apal, rs7975232) was significantly associated with cognition (word recall and digit-symbol coding). CONCLUSIONS: There is an association between serum 25(OH)D and cognition, but randomized controlled trials are needed to establish causality.
BACKGROUND AND PURPOSE: There are indications that vitamin D may be important for more than skeletal health, including cognitive function. METHODS: The study was performed in Tromsø, Northern Norway (The Tromsø Study). In a cross-sectional study serum 25-hydroxyvitamin D (25(OH)D) was measured and cognitive function (word recall, digit-symbol coding, finger tapping, Mini Mental State Examination) tested in 4624 subjects; in a prospective study serum 25(OH)D was measured in samples from 1994 and compared to cognitive function tested in 3436 subjects in 2001 and 2044 subjects in 2007; and in a Mendelian randomization study single nucleotide polymorphisms (SNPs) related to vitamin D were evaluated versus cognitive function in 5980 subjects. RESULTS: In the cross-sectional study all tests were positively associated with serum 25(OH)D levels with ~5% better performance in subjects in the highest versus lowest serum 25(OH)D quartile. This relation was only seen in subjects older than 65 years. After full adjustment for season, age, gender, body mass index, blood pressure, physical activity and education, the relation was only significant for finger tapping. In the prospective study, serum 25(OH)D from 1994 similarly predicted cognitive function 7-13 years later. In the Mendelian randomization study, only one SNP in the VDR gene (Apal, rs7975232) was significantly associated with cognition (word recall and digit-symbol coding). CONCLUSIONS: There is an association between serum 25(OH)D and cognition, but randomized controlled trials are needed to establish causality.
Authors: May A Beydoun; Sharmin Hossain; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Jose-Atilio Canas; Michele K Evans; Alan B Zonderman Journal: J Clin Endocrinol Metab Date: 2018-04-01 Impact factor: 5.958
Authors: May A Beydoun; Salman M Tajuddin; Greg A Dore; Jose-Atilio Canas; Hind A Beydoun; Michele K Evans; Alan B Zonderman Journal: J Nutr Date: 2017-04-26 Impact factor: 4.798
Authors: J Zugic Soares; R Pettersen; J Saltyte Benth; A B Knapskog; G Selbæk; N Bogdanovic Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: David B Matchar; Choy-Lye Chei; Zhao-Xue Yin; Victoria Koh; Bibhas Chakraborty; Xiao-Ming Shi; Yi Zeng Journal: J Gerontol A Biol Sci Med Sci Date: 2016-07-12 Impact factor: 6.053
Authors: Shan-Yuan Tsai; Vibeke S Catts; Janice M Fullerton; Susan M Corley; Stuart G Fillman; Cynthia Shannon Weickert Journal: Mol Neuropsychiatry Date: 2018-01-16
Authors: Rebecca Carnegie; Jie Zheng; Hannah M Sallis; Hannah J Jones; Kaitlin H Wade; Jonathan Evans; Stan Zammit; Marcus R Munafò; Richard M Martin Journal: Lancet Psychiatry Date: 2019-11-20 Impact factor: 27.083